Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Emx2os (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of EMX2OS mRNA | CTD | PMID:20188158 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EMX2OS mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bisphenol S results in decreased methylation of EMX2OS gene | CTD | PMID:31601247 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of EMX2OS mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of EMX2OS gene | CTD | PMID:27153756 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of EMX2OS mRNA | CTD | PMID:24449571 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of EMX2OS gene | CTD | PMID:25304211 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of EMX2OS gene | CTD | PMID:25304211 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of EMX2OS gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EMX2OS mRNA | CTD | PMID:28628672 and PMID:31601247 | bisphenol A | increases expression | ISO | Emx2os (Mus musculus) | 6480464 | bisphenol A results in increased expression of EMX2OS mRNA | CTD | PMID:32156529 | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of EMX2OS mRNA | CTD | PMID:26079696 | chlordecone | increases expression | ISO | Emx2os (Mus musculus) | 6480464 | Chlordecone results in increased expression of EMX2OS mRNA | CTD | PMID:33711761 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EMX2OS mRNA | CTD | PMID:28628672 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | folic acid | decreases expression | ISO | Emx2os (Mus musculus) | 6480464 | Folic Acid results in decreased expression of EMX2OS mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of EMX2OS gene | CTD | PMID:31601247 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EMX2OS mRNA | CTD | PMID:28628672 | maneb | multiple interactions | ISO | Emx2os (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of EMX2OS mRNA | CTD | PMID:36117858 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of EMX2OS mRNA | CTD | PMID:28001369 | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of EMX2OS mRNA | CTD | PMID:25583101 | paraquat | multiple interactions | ISO | Emx2os (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of EMX2OS mRNA | CTD | PMID:36117858 | perfluorohexanesulfonic acid | increases expression | ISO | Emx2os (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of EMX2OS mRNA | CTD | PMID:37995155 | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of EMX2OS mRNA | CTD | PMID:25812627 | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of EMX2OS mRNA | CTD | PMID:25812627 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of EMX2OS mRNA | CTD | PMID:25812627 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of EMX2OS mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EMX2OS mRNA | CTD | PMID:27188386 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of EMX2OS mRNA | CTD | PMID:29955902 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of EMX2OS mRNA | CTD | PMID:34032870 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of EMX2OS mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EMX2OS mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of EMX2OS mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EMX2OS mRNA | CTD | PMID:27188386 | |